INTEST CORP - 8-K Filing

InTest revises Q2 revenue to $35M, lowers gross margin guidance due to Alfamation mix issues and supply chain delays (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits(d)ExhibitsExhibit No)

SEC EDGAR ·

Tickers: $INTT

Read the full article at SEC EDGAR

More Regulatory news